| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8596024 | Journal of Stroke and Cerebrovascular Diseases | 2017 | 8 Pages |
Abstract
The effect of CL therapy differed by stroke subtypes in preventing neurologic deterioration. CL therapy appeared to be ineffective in branch atheromatous disease. Therefore, the choice of CL therapy should carefully be made according to stroke subtypes.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Yasuko MD, Masahiro MD, Taizen MD, PhD,